Donald W. DeGolyer - Aug 12, 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Aug 12, 2025
Transactions value $
-$67,831
Form type
4
Date filed
8/13/2025, 04:22 PM
Previous filing
May 2, 2025
Next filing
Nov 12, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DeGolyer Donald W Director 300 PROFESSIONAL DR, GAITHERSBURG /s/ Richard S. Lindahl, Attorney-in-fact 2025-08-13 0001583098

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale -$67.8K -7.84K -5.39% $8.65 138K Aug 12, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the Reporting Person to satisfy the Reporting Person's tax obligations resulting from the settlement of vested RSUs on May 22, 2025.
F2 All shares sold at an exact price of $8.6475.